Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04370821 · ClinicalTrials.gov registry record
COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers
A clinical trial of COVID-19 and Occupational Exposure to SARS-CoV-2, sponsored by Villanova University.
- Active
- Registry status
- 2,600
- Enrollment target
- 1
- Study location
NCT04370821: Active study of COVID-19 and Occupational Exposure to SARS-CoV-2, sponsored by Villanova University.
NCT04370821 is a study of COVID-19 and Occupational Exposure to SARS-CoV-2 that is active but no longer recruiting, run by Villanova University. The registered enrollment target is 2,600 participants, below the 38,456-participant average among 298 other COVID-19 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04370821, a study of COVID-19 and Occupational Exposure to SARS-CoV-2, is active but no longer recruiting, sponsored by Villanova University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,600 participants
- Enrollment target
- 1
- Study location
Study Summary
The COVID-19 CHAMPS Study will obtain data on the physical and mental health and well-being of workers potentially exposed to the SARS-CoV-2 virus in the course of their duties. Included are a broad range of occupations including those working in the community (police officers, firefighters, emergency personnel, screening staff) as well as in permanent or temporary sites that care for patients (service staff, nurses, physicians and other health professionals). CHAMPS will obtain data on various exposure factors and health and create a registry of participants for extended follow up and sub-studies.
Conditions Studied
Study Locations (1)
Pennsylvania
- Villanova University - Villanova
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,600 participants |
| Start Date | 2020-05-09 |
| Est. Completion | 2025-01-01 |
What the registry record for NCT04370821 still lists
NCT04370821 is an observational study that tracks outcomes without assigning an intervention. Its 2,600 participants enrollment target places it among the larger protocols in the corpus, below the 38,456-participant average among 298 other COVID-19 trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04370821 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04370821 about?
NCT04370821 is a clinical study titled "COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers". The COVID-19 CHAMPS Study will obtain data on the physical and mental health and well-being of workers potentially exposed to the SARS-CoV-2 virus in the course of their duties. Included are a broad range of occupations including those working in the community (police officers, firefighters, emergen...
What is the current status of trial NCT04370821?
This trial is currently active not recruiting. The enrollment target is 2,600 participants. The study started on 2020-05-09. Estimated completion is 2025-01-01.
What conditions does trial NCT04370821 study?
This clinical trial studies the following conditions: COVID-19, Occupational Exposure to SARS-CoV-2.
Who is sponsoring clinical trial NCT04370821?
This trial is sponsored by Villanova University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04370821 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04370821's enrollment target sits among peer trials
2,600 40th of 298 higher than 259 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI